Solid Biosciences Inc. (SLDB) Total liabilities 2017–2022
Solid Biosciences Inc. (SLDB) total liabilities at each fiscal year-end, per SEC filings.
$48.6MFY2022 · since FY2017: $11.3M → $48.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $48.6M | +101.0% |
| FY2021 | $24.2M | -38.2% |
| FY2020 | $39.1M | +66.9% |
| FY2019 | $23.4M | +62.5% |
| FY2018 | $14.4M | +27.9% |
| FY2017 | $11.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice